Fort Smith, ARKANSAS2 Active Studies

Multiple Sclerosis Clinical Trials in Fort Smith, ARKANSAS

Find 2 actively recruiting multiple sclerosis clinical trials in Fort Smith, ARKANSAS. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
1,200
Enrolling

Recruiting Multiple Sclerosis Studies in Fort Smith

About Multiple Sclerosis Clinical Trials in Fort Smith

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 2 multiple sclerosis clinical trials recruiting participants in Fort Smith, ARKANSAS. These studies are seeking a combined 1,200 participants. Research is being sponsored by Novartis Pharmaceuticals, University of Rochester NCORP Research Base. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Fort Smith — FAQ

Are there multiple sclerosis clinical trials in Fort Smith?

Yes, there are 2 multiple sclerosis clinical trials currently recruiting in Fort Smith, ARKANSAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fort Smith?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fort Smith research site will contact you about next steps.

Are clinical trials in Fort Smith free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fort Smith studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 2 active trials in Fort Smith are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated March 2, 2026 from ClinicalTrials.gov